|
ATE450271T1
(en)
|
|
VACCINE
|
|
DK2073795T3
(en)
|
|
Abuse-safe drug formulation
|
|
CR10571A
(en)
|
|
RECOMBINING VIRIC VACCINE
|
|
DK2066354T3
(en)
|
|
Norovirus vaccine formulations
|
|
DK2346495T4
(en)
|
|
PHARMACEUTICAL FORMULATION 514
|
|
DK2114993T3
(en)
|
|
VACCINE
|
|
BRPI0820381A2
(en)
|
|
Pharmaceutical Formulations
|
|
DK1968631T3
(en)
|
|
VACCINE
|
|
DK2200646T3
(en)
|
|
RNA Vaccines
|
|
DK2234600T3
(en)
|
|
ANTIBODY FORMULATION
|
|
DK2068886T3
(en)
|
|
Lipid-containing preparations
|
|
DK2422810T3
(en)
|
|
Influenza vaccine
|
|
DK3492069T3
(en)
|
|
PHARMACEUTICAL COMPOSITIONS INCLUDING IRON-OXY-HYDROXIDE
|
|
BRPI0715712A2
(en)
|
|
PHARMACEUTICAL COMPOSITION
|
|
BRPI0719393A2
(en)
|
|
Pharmaceutical Composition
|
|
ZA200808489B
(en)
|
|
Nicotine-carrier vaccine formulation
|
|
BRPI0814188A2
(en)
|
|
FORMULATIONS
|
|
DK2069503T3
(en)
|
|
PAPAYAMOSAIKVIRUS-BASED VACCINES AGAINST INFLUENZA
|
|
DK2125048T3
(en)
|
|
Preparation
|
|
DK1978944T3
(en)
|
|
SOFT GELATIN-CAPSULE FORMULATION
|
|
BRPI0716445A2
(en)
|
|
pharmaceutical composition
|
|
BRPI0720234A2
(en)
|
|
PHARMACEUTICAL COMPOSITION
|
|
BRPI0921654A2
(en)
|
|
pharmaceutical formulation
|
|
BRPI0820198A2
(en)
|
|
pharmaceutical compositions
|
|
DK2131818T3
(en)
|
|
NEW DOSAGE FORM
|